Showing results (111-120 of 3,223) with videos related to
Sort By:
Pageof 323
JAMA Oncology|July 25, 2024
Bilateral Mastectomy and Breast Cancer MortalityVasily Giannakeas, David W Lim, Steven A NarodCancer|April 22, 2011
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutationsLouise Bordeleau, Lorraine Lipscombe, Jan Lubinski, et al.Journal of Medical Genetics|October 4, 2011
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genesMohammad R Akbari, Shiyu Zhang, Isabel Fan, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.Annals of Surgical Oncology|June 16, 2011
Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstructionKelly A Metcalfe, John Semple, May-Lynn Quan, et al.Gynecologic Oncology|November 21, 2008
Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based studyKelly A Metcalfe, Isabel Fan, John McLaughlin, et al.British Journal of Cancer|June 17, 2022
Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancerJoanne Kotsopoulos, Neda Zamani, Barry Rosen, et al.Breast Cancer Research and Treatment|April 26, 2013
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance programPål Møller, Astrid Stormorken, Christoffer Jonsrud, et al.Gynecologic Oncology|July 7, 2009
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriersDanielle Vicus, Barry Rosen, Jan Lubinski, et al.Gynecologic Oncology|September 12, 2006
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective studyMario E Beiner, Amy Finch, Barry Rosen, et al.Pageof 323